
    
      Methods: CF children (0-18 years) with a new isolation of Pa from the airway were randomized
      to tobramycin inhalation solution (TOBI® 2x300 mg for 28 days) (TIS) or inhaled
      colistimethate sodium (Colistineb® 2x2 mill U daily) plus oral ciprofloxacin (30mg/kg/day)
      for 3 months (CC). The primary outcome was eradication at end of treatment. Secondary outcome
      parameters were time to Pa relapse, total and Pa specific IgG, FEV1, BMI and Pa status.
    
  